Creating Best In Class Antivirals In Post-COVID China: Interview with Huahui Health CSO Li Wenhui

COVID-19 has highlighted the need for potent, safe and effective antiviral therapies for infectious diseases and now one well-known Chinese researcher is tackling hepatitis B and D though a homegrown drug discovery approach. He talks to Scrip in this wide-ranging audio interview.  

China Biotech CEO Podcast

With severe acute respiratory syndrome (SARS) in 2003 and then COVID-19, China has seen two pandemics originate and spread fast in the country, which has also become known for its large scientific talent pool and boom in research papers. 

A virology researcher by training, Li Wenhui was among the first in 2003 to identify the cellular receptor for SARS virus

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from China

More from Focus On Asia